about
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for au...
Read More
5.40
-0.18
(-3.23%)
1.2M
XNAS Volume
XNAS 30 Jan, 2026 4:13 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Savara Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..